



OPTIMIZATION OF FORMULATION OF FLOATING HYDROGELS CONTAINING GAS FORMING 
AGENT USING RESPONSE SURFACE METHODOLOGY 
Original Article 
 
SUGUNA SELVAKUMARAN1, IDA IDAYU MUHAMAD1,2 
1Department of Bioprocess Engineering, Faculty of Chemical Engineering, 2
 Received: 23 May 2014 Revised and Accepted: 05 Jul  2014 
Cardiovascular Eng. Centre, IJN-UTM, Faculty of Bioscience and 
Medical Engineering Universiti Teknologi Malaysia Johor Bahru 81310, Johor. 
Email: idaidayu@utm.my 
ABSTRACT 
Objective: The objective of present study was to determine the optimum gas forming agent concentration to enhance the floating ability and drug 
release pattern of floating hydrogels by using factorial design. 
Methods: In this article calcium carbonates as gas forming agents was synthesized in modified floating kappa carrageenan hydrogels. Ranitidine 
Hydrochloride was used as drug. 32 full factorial design was utilized for the optimization of gas forming agents. Polymer ratio (X1) and calcium 
carbonates concentration (X2
Results: From the factorial batches, it was observed that formulation containing 0.5% of calcium carbonates with 80:20 ƙC : NaCMC showed the 
optimum floating properties, swelling ratio, drug entrapment efficiency and cumulative drug release. 
) were used as independent variables. The floating hydrogels were characterized and the results obtained are swelling 
ratio study, drug entrapment efficiency, floating lag time and cumulative drug release. 
Conclusion: Thus, formulation containing 0.5% of calcium carbonates with 80:20 ƙC :NaCMC appear to be a potential approach to develop sustains 
drug release in gastrointestinal condition. 
Keywords: Floating hydrogels, Calcium carbonates, Kappa carrageenan, Sodium salt of carbomethylcellulose, Ranitidine hydrochloride, 
Optimization, Factorial design. 
 
INTRODUCTION 
A floating drug delivery system is one of the approaches for 
achieving prolonged and controlled drug release in the 
gastrointestinal tract[1]. FDDS has lower density than gastric fluid 
that remains float in the stomach for a long period of time with 
continuous release of drug [2]. The FDDS use matrices prepared 
with swellable polymers such as kappa carrageenan, sodium 
alginates and gas forming agents such as sodium bicarbonates or 
calcium carbonates [3, 4]. Once the carrier reached the stomach, the 
carbon dioxide is released from the matrix thus decreasing its 
specific gravity which causes an upward motion of the dosage form 
to float on the top of the chime. The carbonates present in the matrix 
enhance the floating properties of the dosage form and also render 
the initial alkaline microenvironments for the polymers to gel [5]. 
In normal conventional optimization process, a single independent 
variable is varied while all others are kept constant at specific set of 
conditions. During the formulation development, it is very hard to 
change more than one parameter at a time. This approach may lead 
to unpredictable result and incorrect conclusion as well as wastage 
of material and time. Response surface methodology (RSM) is an 
alternative method to overcome this problem, which can be used to 
optimize the formulation with suitable experimental design. RSM 
has important applications like optimization and establishing the 
robustness of that product [6,7].  
In order to achieve a good floating carrier, optimization of gas 
generating agents is an essential element. In addition, concentration 
of gas forming agents is also important for sustain drug release. 
Hence response surface methodology is the best method to 
determine the optimal concentration of gas forming agents. Jagdale 
et al. (2011) [8] used 32
Kappa carrageenan is a natural polymer that consistsof sulfated 
polysaccharide with a repeating d-galactose and 3, 6-anhydro-D-
galactose units[9, 10]. ƙC has numerous applications in food, non-
food, pharmaceutical and other industries including indrug delivery 
system[11], wound dressing[12], tissue engineering[13]and others. 
Currently kappa carrageenan hydrogel has been widely used as drug 
carrier for delivery of active substances. This is due to its low 
toxicity, biodegradability and high stability at biological 
environment. ƙC works well in the presence of cellulose derivatives 
such as sodium salt of carbomethyl cellulose. NaCMC has exhibited 
very good swelling behaviorsand has been shown to be both pH-
sensitive and ionic [14, 15]. Ranitidine hydrochloride (RHCl) also 
known as zantac is a competitive, reversible inhibitor of the action of 
histamine at histamine H
 full factorial designs to determine the 
optimum concentration of sodium bicarbonates for maximum 
floating ability along with HPMC K4M as independent variables. 
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MATERIALS AND METHODS 
-receptors, including receptors on gastric 
cells with a minimal effect on H1-receptors. Ranitidine is used to 
treat duodenal ulcers, gastric ulcers, gastro esophageal reflux and 
erosive esophagitis. This drug has a short biological half-life of 
approximately 2-3 hours and an absolute bioavailability of only 50% 
[16, 17]. The objective of the present investigation is to optimize the 
gas forming agents using RSM. In this study kC:NaCMC and calcium 
carbonates concentration were selected as independent variables 
while swelling study, floating lag time and cumulative drug release 
were selected as dependent variables.  
Material 
Ranitidine hydrochloride were obtained from Pusat Kesihatan UTM, 
Kappa-Carrageenan (қC)  was purchased from Sigma-
Aldrich,(Malaysia), Sodium Carboxymethyl Cellulose (NaCMC) 
(average molecular weight of 250,000) was purchased from Acros 
Organic,(Malaysia), Calcium Carbonate (CaCO3
Methods 
)was purchased from 
QRec, (Malaysia). Distilled water in used in hydrogel synthesis and 
all chemicals are used as received with no additional purification. 
Preparation of sample 
Preparation of floating hydrogels 
Floating hydrogel was prepared by traditional mixing method. A 
solution was prepared by dissolving 150 mg of drug in 5 ml distilled 
water. The above solution was added to the hot solution of ƙC/ 
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 in 25 ml at 80 ˚C under reflux.  The solution was 
stirred for 1 h to obtain a clear, viscous and homogenous solution 
with no bubbles. Then, the resultant hot solution was poured into 
ceramic moulds to form the hardened hydrogel of a desired shape. 
Samples were equilibrated with ambient temperature (25 °C) for 24 
hours prior to drying at 37 °C in over-night. Table 1 lists the 
synthesis condition for the preparation of floating hydrogels.Table 1 
lists the synthesis condition of floating hydrogel in this experiment.
Table 1: Synthesis condition of Floating Hydrogels 
Sample Designation ƙc (g) NaCMC (g) CaCO3 Water (ml)  (g) 
ƙC70-0.5% 0.42 0.18 0.15 30 
ƙC70-1.5% 0.42 0.18 0.45 30 
ƙC70-2.0% 0.42 0.18 0.6 30 
ƙC80-0.5% 0.48 0.12 0.15 30 
ƙC80-1.5% 0.48 0.12 0.45 30 
ƙC80-2.0% 0.48 0.12 0.6 30 
ƙC90-0.5% 0.54 0.06 0.15 30 
ƙC90-1.5% 0.54 0.06 0.45 30 
ƙC90-2.0% 0.54 0.06 0.6 30 
 
Measuring swelling ratio 
To study the swelling properties of hydrogels, modified gels were 
immersed in different pH buffer solution of pH 1.2 at room 
temperature (25 °C). Synthesized gels were placed in a Petri dish 
filled with 50 ml of each buffer solution. Prior to weighting, filter 
paper was used to remove the surface water of swollen hydrogel. 
The swelling ratio (%) was then determined using Eq. (1) 
Swelling ratio (%) = [Wt−Wo
Wo
] X 100%............... (1) 
where W0 is the initial weight of samples and Wt is the weight of 
swollen gels at predetermined time t. To allow hydrogels to reach 
their highest swelling ability, they were immersed in fresh buffer 
solution after weighting. The test was conducted in triplicate and 
reported as mean values to maximize accuracy. 
Drug entrapment efficiency 
For entrapment efficiency hydrogels (150 mg) were powdered and 
dissolved in 10 ml of 0.1 N HCl. It was sonicated for 30 min and then 
diluted to 100 ml with 0.1 N HCl. It was then filtered through 
Whatman filter paper no. 41. Suitable dilutions were made and the 
filtrate was analyzed spectrophotometrically at 313 nm. Entrapment 
efficiency can be calculated by Eq. (2) 
Entrapment Efficiency (%) = [ Mass of drug in the carrier
Mass of drug used in formulation
]X 100%........ (2) 
In vitro buoyancy study 
Floating properties of қC :NaCMC:CaCO3
In vitro Release 
hydrogels were evaluated 
with 50 ml of 0.1 N HCl at 37 °C ± 0.1 ̊C.  The time required for 
hydrogel to rise to the surface and float (floating lag time) were 
measured by visual observation[18]. 
The samples were immersed in beakers filled with 50 ml of 0.1 N HCl 
and placed in an incubator at 37 °C ± 0.5 ̊ C.  20 ml of the sample was 
withdrawn at time intervals, filtered, diluted suitably and analyzed 
spectrophotometrically at 313 nm. Equal amount of fresh medium 
was replaced immediately after withdrawal of the test sample. The 
amount of Ranitidine hydrochloride was calculated by interpolation 
from the Ranitidine hydrochloride standard curve at 313 nm. 
Experimental design 
In this full 32 factorial experiment design were evaluated, each at 3 
levels, and experimental trials were performed on all 9 possible 
combinations. The polymer to ƙC:NaCMC ratio (X1) and gas 
generating agents (X2) were selected as independent variables. 
Swelling degree (%), drug entrapment efficiency (%), in vitro 
buoyancy and in vitro drug release (%) were selected as dependent 
variables.Table 2 shows translation of coded levels in actual units. 
The data were subjected to multiple regression analysis using 
statistical software (Statistica. Inc version 8). The model 
incorporating first order polynomial terms was used to evaluate the 
responses and Eq. (3) was: 
Y = b0 + b1X1 + b2X2 + B12 X1X2 + b11 X1 2 + b22X2
where, Y is the dependent variable, b
(3) 
0  is the arithmetic mean 
response of 9 runs and b1  is the estimated coefficients for the related 
factor X1 . The main effect (X1  and X2) represents the average result 
of changing one factor at a time from its low to high value. The 
interaction term “X1X2” shows how the response changes when the 
two factors change simultaneously. The polynomial terms (X1 2and 
X2 2
 
) are included to investigate non-linearity. Each experiment was 
conducted in triplicate and the mean determined. 
Table 2: Translation of coded levels in actual units 
Variables level Low (-1) Medium (0) High (1) 
Polymer ratio  70:30 80:20 90:10 
CaCO3 0.5  Concentration (%)  1.5 2.0 
 
Data analysis 
To compare the differences between the formulations, statistical 
analysis was carried out using the analysis of variance (ANOVA) 
using (Statistica. Inc version 8). At the 95% confidence interval, p 
values, less than or equal to 0.05 were considered significant.  
RESULT AND DISCUSSION 
Swelling Ratio Study 
Factorial equation for swelling ratio (%) = 4969.43-103.93X1-
233.664X2 + 0.625X1 2 –162.94X2 2 – 4.175X1X
Swelling ratio (%) for all formulas F1 to F9 varied from 488.09% to 
143.9% (Table 3) showed good correlation as 0.9256. In the above 
equation, coefficient of X1 showed negative value sign, so increased 




This is because as ƙC content increased the gel structure became 
harder and hindered the water absorption into hydrogel network, 
whereby higher NaCMC content caused the stability of the hydrogel 
decreases due to matrix erosion[14]. On the other hand hydrogel 
 showed negative sign, so increase in calcium 
carbonates decreased swelling study.  
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might have provided a barrier that hinders absorption of water into 
hydrogel matrix. Swelling ratio decreases with high calcium 
carbonates concentration. The presence of calcium carbonates in the 
hydrogel carrier could neutralize the gastric fluid of swollen region 
to a neutral pH or even to alkaline pH. In neutral and alkaline 
environmentthe hydrogel cannot swell well hence the swelling ratio 
decreases with increased calcium carbonates concentration[19].  
It can be concluded that both concentrations of X1 and X2
 
 were 
responsible for the swelling ratio. 



















X X1 X2 X1 2 
ƙC70-0.5% -1 -1 70:30 0.5 488.09 96.93 3.60 45.61 
ƙC70-1.5% -1 0 70:30 1.5 370.28 62.01 2.62 60.14 
ƙC70-2.0% -1 1 70:30 2.0 363.76 56.01 1.30 109.89 
ƙC80-0.5% 0 -1 80:20 0.5 487.31 90.00 2.24 40.70 
ƙC80-1.5% 0 0 80:20 1.5 134.53 54.60 1.68 51.32 
ƙC80-2.0% 0 1 80:20 2.0 126.56 49.21 1.55 88.99 
ƙC90-0.5% 1 -1 90:10 0.5 380.12 81.27 2.94 32.26 
ƙC90-1.5% 1 0 90:10 1.5 125.43 69.42 2.42 47.14 
ƙC90-2.0% 1 1 90:10 2.0 143.9 54.34 1.71 63.07 
 
Table 4: Summary of regression outputs of significant factors for 
Coefficient B0 B1 B11 B2 B22 B12 R2 
Swelling Ratio Study  4969.43 -103.93 0.625 -233.66 162.94 -4.175 0.9256 
Drug Entrapment Efficiency 524.64 -9.59 -0.054 -85.28 6.57 0.5593 0.9539 
Floating Lag Time 45.8 -1.031 0.006 -2.39 -0.502 0.034 0.89721 
Cumulative Drug Release 15.11 1.10 -0.006 15.60 37.04 -0.954 0.9058 
 
Table 5: Result of two-way ANOVA for dependent variables 
 Source Degree of freedom Sum of squares Mean SQUARE F-value P-value 















































































Drug entrapment efficiency 
Factorial equation for entrapment efficiency (%) = 524.64 – 9.59X1 – 
85.28 X2-0.054X12 + 6.57X22+ 0.5593X1X
Entrapment Efficiency (%) for all formulas F1 to F9 varied from 
96.93% to 54.34% (Table 3) showed good correlation as 0.9539. In 
the above equation, coefficient of X
2 
1and X2 showed negative value 
sign, so increased polymer and calcium carbonates concentration 
decreased the drug entrapment efficiency in 0.1 N HCl. The result of 
two way ANOVA presented in Table 5 showed that the concentration 
of calcium carbonates significantly (p< 0.05) affected the floating lag 
time while the effect of polymers was not statistically significant. 
Thus factor X2is more responsible than factor X1 for drug 
entrapment efficiency. This is because the reaction between gas 
forming agent and 0.1 N HCl (stimulated gastric fluid) cause carbon 
oxide generation, which permeates the hydrogel networks, leaving 
pores. High CaCO3
Therefore, as the calcium carbonates concentration increases the 
drug entrapment efficiency decreases. Calcium carbonates 
concentration has been found to have a more pronounced effect on 
drug entrapment efficiency.  
 concentration form many pores in hydrogel 
matrix and make the internal structure of hydrogel become less 
dense, with the result that drugs cannotbe retained in hydrogel 
network [20].  
Floating lag time 
Factorial equation for floating lag time (min) = 45.86 – 1.03145X1 – 
2.39 X2 + 0.00612 X1 2-0.50222 X2 2+ 0.02288 X1X
Floating lag time (min) for all batches F1 to F9 varied from 3.60 min 
to 1.71 min (Table 3) showed good correlation coefficient as 0.9647. 
Floating hydrogel is expected to remain float in the stomach without 
2 
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affecting the gastric emptying rate for a prolonged period of time. In 
the above equation, coefficients of both X1 and X2 showed negative 
value sign, so increased polymer and calcium carbonates 
concentration decreased the floating lag time of hydrogels in 0.1 N 
HCl. When the hydrogel comes into contact with acidic medium, 
calcium carbonates effervesces, releasing C02 which make the 
hydrogel remain float over the surface.  
The released CO2 lowers the hydrogel density and makes them float 
for a prolonged time. The result of two way ANOVA presented in 
Table 5 shows that the concentration of calcium carbonates 
significantly (p< 0.05) affected the floating lag time while the effect 
of polymers was not statistically significant. Thus factor X2 wasmore 
responsible than factor X1 for floating lag time.  
Cumulative drug release 
Factorial equation for cumulative drug release (%) = 15.11 + 1.10 X1 
+ 15.60 X2 – 0.006 X1 2 + 37.035 X2 2-
Cumulative drug release (%) for all formulas F1 to F9 varied from 
109.89 % to 32.26 % (Table 3) showed good correlation coefficient 
as 0.90578. In the above equation, coefficient of X
0.954X1X2 
1 and X2 showed 
positive value sign, so increased polymer and calcium carbonates 
concentration increased the cumulative drug release in 0.1 N HCl. 
The result of equation indicates X2 was more responsible than X1 for 
cumulative drug release. The result from the two way ANOVA 
indicates that both polymer and calcium carbonates concentration 
significantly (p < 0.05) affected the cumulative drug release. This is 
because as the effervescent reaction occurs between acidic medium 
and gas forming agents, CO2is released and pores are left in hydrogel 
network as well. Thus drug release mainly depends on pore 
formation. As the gas forming agent’s concentration increases, more 
pores will be left it is on hydrogel matrix and more drugs will be 
released within the pores. On the other hand polymers help to make 
the gel network more porous. The result of two way ANOVA 
presented in table 5 showed that both X1 and X2
  
 factor are 
statistically significant (p< 0.05). 
 
(A)     (B) 
 
(C)     (D) 
Fig. 1: Surface graphs showing effect of variables on (a) swelling ratio, (b) drug entrapment efficiency, (c) floating lag time and (d) 
cumulative drug release. 
 
CONCLUSION 
In the present study, floating hydrogels containing 0.5% calcium 
carbonate with polymer ratio 80:20 ƙC:NaCMC showed the optimum 
result for all variables tested. This formulation shows a good floating 
ability, high drug entrapment efficiency and also a steady and 
sustained drug release in gastrointestinal tract.  
It can be concluded that 0.5% calcium carbonate is sufficient for 
appropriate floating propertiesof hydrogelsand controlled drug 
release as well. 
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